Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02625116Active Not Recruiting

ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders

Role: collaborator

NCT02335177Not ApplicableCompleted

Technology and Human Help at Home After Hospitalisation

Role: collaborator

NCT00646269Phase 3Completed

Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease

Role: collaborator

NCT01437683Completed

PariS-TBI Study : Paris Severe Traumatic Brain Injury Study

Role: collaborator

All 4 trials loaded